Vivek Upreti
About Vivek Upreti
Vivek Upreti has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Aqumen Labs Private Limited and Instaqa Private Limited. Formerly with 3 companies, such as Hello Fitness Private Limited and Quiqua Infotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Aqumen Labs Private Limited
U62099UP2024PTC206077
|
Director | 09 Jul 2024 | 2024 | Active |
Instaqa Private Limited
U72200DL2022PTC397685
|
Director | 22 Mar 2024 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Hello Fitness Private Limited
U92490UP2021PTC141243
|
Director | 04 Feb 2021 | 2021 | Active |
Quiqua Infotech Private Limited
U56210UP2019PTC112962
|
Director | 29 Jan 2019 | 2019 | Active |
Qainfinity Private Limited
U72900HR2019PTC084311
|
Director | 23 Dec 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Upreti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Upreti
Vivek Upreti has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Aqumen Labs Private Limited and Instaqa Private Limited. Formerly with 3 companies, such as Hello Fitness Private Limited and Quiqua Infotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Vivek Upreti is associated with 2 companies as Director.
Vivek Upreti has expertise in General Business, Technology.
Vivek Upreti has 7 years in corporate governance.